-
$4,995 Read More Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 – Strong Pipeline and Expanding Treatment Population to [...]
Type 2 Diabetes Mellitus (T2DM) is a metabolic disease characterized by chronic hyperglycemia (high blood glucose levels). Global prevalence has risen rapidly in the past several decades, particularly in line with obesity. This has been attributed to a range of factors, including economic develop... -
$4,995 Read More Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 – Advent of Novel Biologics and Expanding Treatment Pool to Drive[...]
GBI Research, the leading business intelligence provider, has released its latest research, "Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth", which provides insights into psoriasis therapeutics in the Asia-P... -
$4,700 Read More Biodefense Market Analysis By Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Ebola, Hemorrhagic Fever) And Segment Forecasts [...]
Global biodefense market is expected to reach USD 13.33 billion by 2020. Growing R&D investments in the field of biotechnology coupled with increasing threat of bioterrorism and disease outbreaks is expected to drive market growth during the forecast period. Furthermore, presence of favorable... -
$4,700 Read More Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT[...]
Global antidiabetics market is expected to reach USD 84.13 billion by 2020. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by tri... -
$4,700 Read More Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis By Product (Corticosteroids, Intravenous Immunoglobulin, Anti-D [...]
Global ITP therapeutics market is expected to reach USD 566.37 million by 2020. Introduction of new drugs especially pertaining to TPO-RA and IVIG classes is expected to serve this market as a high impact rendering driver. Presence of favorable government regulations such as the Orphan Drug Act i... -
$4,700 Read More Autoimmune Disease Diagnostics Market Analysis By Product (Systemic, Localized, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ank[...]
Global autoimmune disease diagnostics market is expected to reach USD 14.17 billion by 2020. Growing prevalence of autoimmune diseases coupled with the presence of favorable government initiatives such as the Affordable Care Act is expected to positively reinforce the autoimmune disease diagnosti...
Sorry, there is no ad related to this category!
-
$1,500 Read More Clevexel Pharma SAS – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Clevexel Pharma SAS – Product Pipeline Review – 2015’, provides an overview […]
-
$2,000 Read More Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Candidiasis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Candidiasis – Pipeline Review, H1 2016’, provides an overview of the Candidiasis […]
-
$6,995 Read More Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) – Identifyin...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the […]
-
$1,995 Read More CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Indones...
The report is an essential source of information on and analysis of the healthcare, regulatory […]
-
$2,000 Read More Botulism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Botulism – Pipeline Review, H1 2016’, provides an overview of the Botulism […]
-
$2,500 Read More Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Herpes Labialis (Oral […]
-
$6,995 Read More Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma (NHL) can be seen as a collection of up to 60 smaller subtypes […]
-
$2,000 Read More Hyperalgesia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Hyperalgesia – Pipeline Review, H1 2016’, provides an overview of the Hyperalgesia […]
-
$2,000 Read More Colitis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Colitis – Pipeline Review, H1 2016’, provides an overview of the Colitis […]
